Literature DB >> 11932737

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Monica Bucciantini1, Elisa Giannoni, Fabrizio Chiti, Fabiana Baroni, Lucia Formigli, Jesús Zurdo, Niccolò Taddei, Giampietro Ramponi, Christopher M Dobson, Massimo Stefani.   

Abstract

A range of human degenerative conditions, including Alzheimer's disease, light-chain amyloidosis and the spongiform encephalopathies, is associated with the deposition in tissue of proteinaceous aggregates known as amyloid fibrils or plaques. It has been shown previously that fibrillar aggregates that are closely similar to those associated with clinical amyloidoses can be formed in vitro from proteins not connected with these diseases, including the SH3 domain from bovine phosphatidyl-inositol-3'-kinase and the amino-terminal domain of the Escherichia coli HypF protein. Here we show that species formed early in the aggregation of these non-disease-associated proteins can be inherently highly cytotoxic. This finding provides added evidence that avoidance of protein aggregation is crucial for the preservation of biological function and suggests common features in the origins of this family of protein deposition diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11932737     DOI: 10.1038/416507a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  711 in total

1.  The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35.

Authors:  Jörg Gsponer; Urs Haberthür; Amedeo Caflisch
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

2.  Short peptide amyloid organization: stabilities and conformations of the islet amyloid peptide NFGAIL.

Authors:  David Zanuy; Buyong Ma; Ruth Nussinov
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

3.  Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptides.

Authors:  Abdessamad Tahiri-Alaoui; Mario Bouchard; Jesús Zurdo; William James
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

4.  Mutations in the B1 domain of protein G that delay the onset of amyloid fibril formation in vitro.

Authors:  Marina Ramírez-Alvarado; Melanie J Cocco; Lynne Regan
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

Review 5.  Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions.

Authors:  Arthur Horwich
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  The cellular response to aggregated proteins associated with human disease.

Authors:  David H Perlmutter
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 7.  Translational control in the endoplasmic reticulum stress response.

Authors:  David Ron
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

8.  Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Authors:  Sofie Nyström; Rajesh Mishra; Simone Hornemann; Adriano Aguzzi; K Peter R Nilsson; Per Hammarström
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 9.  An emerging concept of prion infections as a form of transmissible cerebral amyloidosis.

Authors:  Omar Lupi; Marcius Achiame Peryassu
Journal:  Prion       Date:  2007 Oct-Dec       Impact factor: 3.931

10.  Free-solution label-free detection of alpha-crystallin chaperone interactions by back-scattering interferometry.

Authors:  Joey C Latham; Richard A Stein; Darryl J Bornhop; Hassane S Mchaourab
Journal:  Anal Chem       Date:  2009-03-01       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.